logo
#

Latest news with #diagnostic

Cheaper brain cancer test provides more accurate results in just 2 hours
Cheaper brain cancer test provides more accurate results in just 2 hours

Independent Singapore

time7 days ago

  • Business
  • Independent Singapore

Cheaper brain cancer test provides more accurate results in just 2 hours

UK: A cheaper and faster brain cancer test developed by UK researchers can now identify the type of brain tumour in just two hours, offering more accurate results than current methods, PA Media reported. Patients typically wait six to eight weeks to determine the type of brain tumour they have, as samples are sent to central laboratories for genetic analysis. Experts said this long wait can be 'traumatic' and delay treatment like chemotherapy or radiotherapy. With the new test, diagnostic results can be ready in under two hours after surgery, with detailed tumour classifications available within minutes of sequencing. Researchers from the University of Nottingham and Nottingham University Hospitals NHS Trust (NUH) have developed a new method called ROBIN, short for rapid nanopore brain intraoperative classification, which assesses the deoxyribonucleic acid (DNA) from a tumour sample. The test was applied to 50 patients and was in concordance with the standard of care in 90% of cases, according to findings published in Neuro-Oncology . Dr. Matt Loose, a professor of developmental and computational biology at the University of Nottingham, developed a method to sequence specific parts of human DNA using portable sequencing devices from Oxford Nanopore Technologies, which offers real-time analysis. Now, the team has used it to test brain tumour samples genetically. NUH neurosurgeon Dr Stuart Smith said, 'Patients find waiting many weeks for results extremely difficult and this adds to the anxiety and worry at what is already a very difficult time.' Meanwhile, NUH consultant neuropathologist Dr Simon Paine said that the method will be a 'game changer,' pointing to the speed at which results will be available and the degree of accuracy of the diagnosis. Dr. Simon Newman, Chief Scientific Officer of The Brain Tumour Charity, added that the new method will be 'transformative for all patients' as it ensures rapid access to an optimal standard of care and, crucially, removes the uncertainty patients face in waiting weeks for their diagnosis and prognosis. /TISG Read also: New white paper warns of the cost of inaction on youth mental health across APAC

NYU Abu Dhabi researchers develop paper-based diagnostic tool for infectious disease detection
NYU Abu Dhabi researchers develop paper-based diagnostic tool for infectious disease detection

Emirates 24/7

time02-06-2025

  • Health
  • Emirates 24/7

NYU Abu Dhabi researchers develop paper-based diagnostic tool for infectious disease detection

A team of scientists at NYU Abu Dhabi has developed a breakthrough paper-based diagnostic device that can detect COVID-19 and other infectious diseases in under 10 minutes, without the need for sophisticated lab equipment or trained personnel. The Radially Compartmentalized Paper Chip (RCP-Chip), engineered by researchers at the Advanced Microfluidics and Microdevices Laboratory (AMMLab), offers a fast, affordable, and portable solution for on-site screening of infectious diseases. The RCP-Chip has been developed to detect even minute traces of viral genetic material using a droplet of fluid and a visible color change. It operates without electricity or special equipment, needing just a source of mild heat at around 65°C, similar to the temperature of warm water. The research is detailed in a paper titled Single-Layer Radially Compartmentalized Paper Chip (RCP-Chip) for Rapid Isothermal Multiplex Detection of SARS-CoV-2 Gene Targets, published in the journal Advanced Sensor Research. The study reports the development and validation of the RCP-Chip as a rapid, multiplexed diagnostic platform for infectious disease detection suitable for low-resource settings. NYUAD Associate Professor of Mechanical Engineering and Bioengineering and senior author Mohammad A. Qasaimeh said, 'The RCP-Chip is designed for real-world impact. It can be reconfigured to detect other infectious diseases, making it a powerful tool for global health.' 'This is a fast, affordable, lab-free test that detects multiple gene targets in under 10 minutes,' said NYUAD Research Assistant and co-first author of the study Pavithra Sukumar. 'What makes it truly impactful is its real-world potential. This portable test could significantly improve outbreak response by enabling faster isolation, treatment, and control.' Follow Emirates 24|7 on Google News.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store